We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$188M
2
AMZN icon
Amazon
AMZN
+$137M
3
ADBE icon
Adobe
ADBE
+$110M
4
EA
Electronic Arts
EA
+$110M
5
PFE icon
Pfizer
PFE
+$109M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
76
Gilead Sciences
GILD
$165B
$55.8M 0.39%
858,224
-135,082
-14% -$8.98M
BAC icon
77
Bank of America
BAC
$442B
$55.6M 0.39%
2,015,485
-726,222
-26% -$20.5M
ABMD
78
DELISTED
Abiomed Inc
ABMD
$54.4M 0.39%
190,510
+11,194
+6% +$3.72M
LIN icon
79
Linde
LIN
$226B
$53.5M 0.38%
304,185
+28,496
+10% +$4.73M
GWPH
80
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$53.4M 0.38%
316,899
+297,858
+1,564% +$44.3M
NKE icon
81
Nike
NKE
$61.9B
$51.7M 0.37%
613,621
-531,977
-46% -$43.9M
NBIX icon
82
Neurocrine Biosciences
NBIX
$16.6B
$51.2M 0.36%
580,904
+264,402
+84% +$22.1M
ROST icon
83
Ross Stores
ROST
$81.9B
$49.8M 0.35%
535,365
-229,279
-30% -$21M
SBUX icon
84
Starbucks
SBUX
$120B
$48.9M 0.35%
657,444
+609,602
+1,274% +$41.9M
CHTR icon
85
Charter Communications
CHTR
$18.2B
$47M 0.33%
135,493
-130,290
-49% -$42.9M
AVGO icon
86
Broadcom
AVGO
$2.04T
$46.8M 0.33%
1,555,440
+51,730
+3% +$1.4M
TDG icon
87
TransDigm Group
TDG
$67.7B
$46.2M 0.33%
101,811
+40,066
+65% +$16.3M
MDT icon
88
Medtronic
MDT
$112B
$45.5M 0.32%
499,191
+269,925
+118% +$24.2M
OLLI icon
89
Ollie's Bargain Outlet
OLLI
$4.94B
$43.1M 0.31%
505,069
+251,501
+99% +$20.3M
NVR icon
90
NVR
NVR
$17B
$42.2M 0.3%
15,258
+13,348
+699% +$35.1M
META icon
91
Meta Platforms (Facebook)
META
$1.51T
$41.1M 0.29%
246,824
+130,195
+112% +$20.7M
DLTR icon
92
Dollar Tree
DLTR
$25.2B
$40M 0.28%
380,922
+126,434
+50% +$12.4M
MPC icon
93
Marathon Petroleum
MPC
$83.7B
$39.4M 0.28%
658,085
+553,731
+531% +$34.8M
ROL icon
94
Rollins
ROL
$18.2B
$37.3M 0.26%
1,344,249
+207,412
+18% +$5.39M
BECN
95
DELISTED
Beacon Roofing Supply, Inc.
BECN
$36.4M 0.26%
+1,132,419
New +$39.6M
AME icon
96
Ametek
AME
$58.2B
$36.3M 0.26%
437,986
+336,593
+332% +$25.6M
ECL icon
97
Ecolab
ECL
$79.9B
$36.1M 0.26%
204,497
-127,694
-38% -$20.7M
BMRN icon
98
BioMarin Pharmaceuticals
BMRN
$12.4B
$36M 0.25%
405,075
-314,680
-44% -$29.2M
ASH icon
99
Ashland
ASH
$3.5B
$35.7M 0.25%
457,012
+293,352
+179% +$22.6M
EL icon
100
Estee Lauder
EL
$32B
$34.9M 0.25%
210,950
+200,972
+2,014% +$29.5M
2 3
4
5 6

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.